| Microorganism |
MIC50
(μg/ml) |
MIC90
(μg/ml) |
Range
(μg/ml) |
Antimicrobial |
Reference |
| Staphylococci |
- |
- |
1 － 32 |
Cefoxitin (Mefoxin)  |
401 |
| Staphylococci |
- |
- |
1 － 32 |
Chloramphenicol (Chloromycetin) |
1440 |
| Staphylococci |
- |
- |
1 － 128 |
Cefpodoxime |
401 |
| Staphylococci |
- |
- |
1 － 128 |
Ceftizoxime (Cefizox) |
401 |
| Staphylococci |
- |
- |
2 － 8 |
Amoxicillin-clavulanic acid (Augmentin) |
1440 |
| Staphylococci |
- |
- |
2 － 16 |
Chloramphenicol (Chloromycetin) |
401 |
| Staphylococci |
- |
- |
2 － 16 |
Gentamicin (Gentamycin, Garamycin) |
1440 |
| Staphylococci |
- |
- |
2 － 32 |
Cephalothin (Cefalotin, Keflin, Seffin) |
1440 |
| Staphylococci |
- |
- |
2 － 128 |
Ceftazidime (Ceptaz, Fortaz, Tanicef) |
401 |
| Staphylococci |
- |
- |
4 － 64 |
Cefixime (Suprax) |
401 |
| Staphylococci |
- |
- |
10 － 320 |
Co-trimoxazole (Trimethoprim-sulfamethoxazole, TMP-SMX) |
1440 |
| Staphylococci |
- |
- |
12 － 128 |
Oxacillin (Prostaphilin, Bactocil, Prostaphlin) |
401 |
| Staphylococci |
- |
- |
16 － 128 |
Nalidixic acid (NegGam) |
401 |
| Staphylococci |
- |
- |
>128 － ? |
Aztreonam (Azactam) |
401 |
| Staphylococci (CN11 + coagulase-negative + methicillin-resistant) |
- |
- |
0.5 － ? |
Daptomycin (Cubicin) |
207 |
| Staphylococci (CN11 + coagulase-negative + methicillin-resistant) |
- |
- |
0.5 － ? |
Oritavancin (LY333328) |
207 |
| Staphylococci (CN11 + coagulase-negative + methicillin-resistant) |
- |
- |
1 － ? |
Quinupristin/Dalfopristin (Synercid) |
207 |
| Staphylococci (CN11 + coagulase-negative + methicillin-resistant) |
- |
- |
1 － ? |
Teicoplanin (Targocid) |
207 |
| Staphylococci (CN11 + coagulase-negative + methicillin-resistant) |
- |
- |
2 － ? |
LBM415 (NVP-PDF-713, VIC-10495) |
207 |
| Staphylococci (CN11 + coagulase-negative + methicillin-resistant) |
- |
- |
2 － ? |
Ranbezolid (RBX 7644) |
207 |
| Staphylococci (CN11 + coagulase-negative + methicillin-resistant) |
- |
- |
2 － ? |
Vancomycin (Vancocyn, Lyphocin) |
207 |
| Staphylococci (CN11 + coagulase-negative + methicillin-resistant) |
- |
- |
4 － ? |
Gatifloxacin (Tequin) |
207 |
| Staphylococci (CN11 + coagulase-negative + methicillin-resistant) |
- |
- |
4 － ? |
Linezolid (PNU-100766, U-100766, Zyvox) |
207 |
| Staphylococci (CN11 + coagulase-negative + methicillin-resistant) |
- |
- |
8 － ? |
Moxifloxacin (BAY 12-8039, Avelox) |
207 |
| Staphylococci (CN11 + coagulase-negative + methicillin-resistant) |
- |
- |
>32 － ? |
Ciprofloxacin (Cipro, Ciproxin, Ciprobay) |
207 |
| Staphylococci (CN11 + coagulase-negative + methicillin-resistant) |
- |
- |
32 － ? |
Levofloxacin (Levaquin, Quixin) |
207 |
| Staphylococci (CN18 + coagulase-negative + methicillin-resistant) |
- |
- |
0.125 － ? |
Ranbezolid (RBX 7644) |
207 |
| Staphylococci (CN18 + coagulase-negative + methicillin-resistant) |
- |
- |
0.25 － ? |
Quinupristin/Dalfopristin (Synercid) |
207 |